Mingjie Shi
- Topics
- Immune cells in cancer (5 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Effects and risks of endocrine disrupting chemicals (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaJournal of Controlled ReleaseToxicological Sciences
- Partner nations
- ChinaUzbekistanIndia
In The Last Decade
Mingjie Shi
17 papers receiving 319 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 154
- Immunology 77
- Biomedical Engineering 68
- Cancer Research 54
- Biomaterials 48
Countries citing papers authored by Mingjie Shi
This map shows the geographic impact of Mingjie Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjie Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjie Shi more than expected).
Fields of papers citing papers by Mingjie Shi
This network shows the impact of papers produced by Mingjie Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjie Shi. The network helps show where Mingjie Shi may publish in the future.
Co-authorship network of co-authors of Mingjie Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Mingjie Shi. A scholar is included among the top collaborators of Mingjie Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjie Shi. Mingjie Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 18 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 13 | |
| 11 | 12 | |
| 12 | 42 | |
| 13 | 34 | |
| 14 | 5 | |
| 15 | 29 | |
| 16 | 19 | |
| 17 | 29 | |
| 18 | 58 | |
| 19 | 51 |
About Mingjie Shi
Mingjie Shi is a scholar working on Immunology, Cancer Research and Physiology, having authored 19 papers that have together received 322 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Biomaterials (48 citations), Immunology (77 citations) and Cancer Research (54 citations). Mingjie Shi has collaborated with scholars based in China, Uzbekistan and India. Frequent co-authors include Yongzhuo Huang, Bin Tu, Yang He, Xuejia Kang, Qin Xu, Huiyuan Wang, Yuge Zhao, Yanrong Gao, Akmal M. Asrorov and Chung‐Kang Peng. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.